OrganoClick AB (SE:ORGC)
:ORGC
Want to see SE:ORGC full AI Analyst Report?
ORGC Stock Chart & Stats
kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.33 - kr2.18
Previous CloseN/A
Volume11.05K
Average Volume (3M)87.89K
Market Cap
kr48.07M
Enterprise Valuekr118.71M
Total Cash (Recent Filing)kr3.05M
Total Debt (Recent Filing)kr77.43M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Jul 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding110,003,010
10 Day Avg. Volume18,569
30 Day Avg. Volume87,893
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.13
Revenue Forecast (FY)kr113.00M
Bulls Say, Bears Say
Bulls Say
Improving Operating Cash FlowOrganoClick’s operating cash flow has shifted positive (TTM +1.8m), indicating the core business can begin to generate cash from operations. If sustained, this reduces reliance on external financing, provides runway to invest in commercialization, and supports deleveraging plans over the medium term.
Bio-based Technology PlatformThe company’s platform focuses on replacing fossil-based chemistries in textiles and wood, aligning with durable structural trends to sustainability and tighter chemical regulations. This technology-led positioning supports long-term B2B demand from manufacturers seeking safer, compliant, and greener inputs.
Sizable Asset BaseA total asset base of ~147.7m provides production capacity, tangible collateral and optionality for scaling commercialization. Coupled with improving operating cash flow, the asset base can be deployed to support manufacturing, licensing, or strategic partnerships that reinforce long-term operational stability.
Bears Say
Declining Revenue TrendRevenue decline (TTM -7.6% and multi-year inconsistent top-line performance) undermines economies of scale and the company’s ability to absorb fixed costs. Sustained top-line weakness impairs margins, limits reinvestment capacity, and increases reliance on financing to fund operations and growth initiatives.
Weak Margins And Persistent LossesLow gross margins (~14–15%) constrain the ability to cover SG&A and R&D, while a ~-35% net margin signals structural profitability issues. Persistent losses reduce internal funding for product development and commercial expansion, making margin recovery essential for long-term viability.
High Leverage And Thin Equity CushionVery high leverage (~5.5x debt-to-equity) with a thin equity base raises refinancing and solvency risk, particularly given negative earnings and negative free cash flow. Elevated debt restricts strategic flexibility, increases interest burden, and magnifies downside if revenue or margin recovery stalls.
OrganoClick AB News
ORGC FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr0.33 and its highest was kr2.18 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is kr48.07M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Jul 17, 2026 which is in 26 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on May 06, 2026. The company reported -kr0.015 earnings per share for the quarter, beating the consensus estimate of -kr0.02 by kr0.005.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 110,003,010 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -kr0.015 in its last earnings report, beating expectations of -kr0.02. Following the earnings report the stock price went up 6.371%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in SE:ORGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Impact Coatings AB
―
XP Chemistries AB
―